LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,764,381 | -22.1% | 41,155 | -20.0% | 0.00% | -100.0% |
| Q2 2023 | $3,548,970 | +93.7% | 51,412 | +35.3% | 0.00% | – |
| Q1 2023 | $1,832,408 | -61.8% | 38,001 | -60.5% | 0.00% | -100.0% |
| Q4 2022 | $4,796,963 | -64.6% | 96,093 | -71.1% | 0.00% | -50.0% |
| Q3 2022 | $13,549,000 | +7.3% | 332,076 | +44.6% | 0.00% | -33.3% |
| Q2 2022 | $12,629,000 | +151.7% | 229,609 | +66.3% | 0.00% | +200.0% |
| Q1 2022 | $5,018,000 | +134.7% | 138,065 | +200.9% | 0.00% | – |
| Q4 2021 | $2,138,000 | -75.6% | 45,880 | -73.5% | 0.00% | -100.0% |
| Q3 2021 | $8,768,000 | +112.5% | 173,425 | +72.5% | 0.00% | +100.0% |
| Q2 2021 | $4,127,000 | -76.5% | 100,561 | -83.4% | 0.00% | -75.0% |
| Q1 2021 | $17,574,000 | +163.7% | 605,614 | +155.9% | 0.00% | +100.0% |
| Q4 2020 | $6,664,000 | -29.3% | 236,649 | -22.5% | 0.00% | -33.3% |
| Q3 2020 | $9,421,000 | +629.2% | 305,176 | +905.2% | 0.00% | – |
| Q2 2020 | $1,292,000 | – | 30,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |